LineaGen Research Corporation Selects Affymetrix (Santa Clara, California) Technology to Discover Genes Associated With Autism and Multiple Sclerosis

SANTA CLARA, Calif., & SALT LAKE CITY--(BUSINESS WIRE)--Affymetrix Inc. (Nasdaq:AFFX) and LineaGen Inc. today announced that a team of prominent researchers at the University of Utah and Vanderbilt University are leveraging Utah’s deep domain expertise in human genetic research and the Affymetrix Genome-Wide Human SNP Array 6.0 to discover genetic markers associated with Multiple Sclerosis (MS) and Autism.